Stockscreener 앱 받기
2.69
5.78%
-0.165
시장 영업 전:
2.68
-0.010
-0.37%
Inmune Bio Inc 주식(INMB)의 최신 뉴스
INmune Bio stock holds steady as Raymond James reiterates Market Perform - Investing.com Nigeria
INmune Bio’s Promising Phase 2 MINDFuL Trial Results Set to Stir Alzheimer’s Market - StocksToTrade
INmune Bio’s Future: Buying, Holding, or Selling? - timothysykes.com
INmune Bio stock up as prostate cancer trial succeeds (INMB) - Seeking Alpha
Volume Profile Shows Strong Base for INmune Bio Inc.Target Return Focused Trade Insights Shared - metal.it
INmune Bio stock soars after prostate cancer trial meets endpoints By Investing.com - Investing.com Nigeria
INmune Bio's Novel NK Cell Therapy Shows Tumor Reduction in Advanced Prostate Cancer Trial - Stock Titan
When is INmune Bio Inc. stock expected to show significant growthFree Bull & Bear Market Updates - Jammu Links News
Is INmune Bio Inc. stock overvalued or undervaluedBuild wealth faster with expert stock selection - Jammu Links News
Is INmune Bio Inc. a growth stock or a value stockDiscover market opportunities with real-time data - Jammu Links News
How does INmune Bio Inc. compare to its industry peersUnlock powerful stock screening techniques - Jammu Links News
What institutional investors are buying INmune Bio Inc. stockBuild wealth faster with disciplined trading - Jammu Links News
What are the technical indicators suggesting about INmune Bio Inc.Build wealth with long-term growth strategies - Jammu Links News
How does INmune Bio Inc. generate profit in a changing economyConsistent triple-digit returns - Jammu Links News
What analysts say about INmune Bio Inc. stockTremendous gains - Jammu Links News
What are analysts’ price targets for INmune Bio Inc. in the next 12 monthsExplosive wealth accumulation - Jammu Links News
Published on: 2025-08-03 15:38:34 - Jammu Links News
What makes INmune Bio Inc. stock price move sharplyUnlock powerful trading alerts for success - Jammu Links News
What is INmune Bio Inc. company’s growth strategyAccelerated wealth building - Jammu Links News
What catalysts could drive INmune Bio Inc. stock higher in 2025Get expert insights on market-moving stocks - Jammu Links News
What drives INmune Bio Inc. stock priceDouble-digit growth - Jammu Links News
Is it the right time to buy INmune Bio Inc. stockFinancial News Planner Backed By Experts - jammulinksnews.com
INmune Bio Inc. May Be Forming Higher Low — Chartwatchers AlertReal Trader Watchlist of Hot Stocks Released - metal.it
Price Channel Expanding on INmune Bio Inc.’s ChartOversold Bounce Stock Play Ideas Gain Attention - metal.it
Inmune Bio Inc. shares fall 1.83% after-hours as the company prepares to report Q2 2025 financial results. - AInvest
INmune Bio Inc. to Host Conference Call on August 7, 2025 for Q2 Results and Corporate Update - Quiver Quantitative
INmune Bio Announces Q1 Earnings Call on August 7th, 2025 at 4:30 PM EDT. - AInvest
INmune Bio Inc. to Report Second Quarter 2025 Financial Results and Provide Corporate Update on Thursday, August 7th - The Manila Times
INmune Bio to Present Q2 2025 Financial Results and Key Clinical-Stage Updates on August 7 - Stock Titan
INmune Bio Inc. recovery potential after sell offRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Inmune Bio shares fall 2.53% premarket after announcing a video detailing MINDFuL trial findings. - AInvest
Inmune Bio Inc. shares fall 4.75% after-hours following the release of a video detailing the MINDFuL trial. - AInvest
INmune Bio Releases Video on Alzheimer’s Trial Results - TipRanks
INmune Bio to Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference - The Manila Times
INmune Bio To Share New Alzheimer's Trial Results On YouTube After Major Conference Reveal - 富途牛牛
INmune Bio to Publish Video on MINDFuL Trial Findings for XPro™ Treatment at Alzheimer's Association International Conference. - AInvest
Breakthrough in Alzheimer's Treatment: Phase 2 Trial Reveals XPro Drug's Impact on Cognitive Decline - Stock Titan
How INmune Bio Inc. stock performs during market volatilityROI Driven Equity Selection With Safety Emphasized - metal.it
Trend Reversal Possible in INmune Bio Inc. Charts IndicateSwing Trade Entry With Volume Triggers Released - metal.it
Is INmune Bio Inc. Stock a Good Fit for Conservative InvestorsDaily Volume Spike Trading Signals Detected - metal.it
Alzheimer’s Breakthrough: INmune Bio’s XPro Trial Shows Promise in Subpopulation - StocksToTrade
INmune Bio Stock Soars 19.56% on Clinical Trial Success - AInvest
INmune Bio Rebounds Sharply During After Hours Trading: What's Driving the Surge? - Benzinga
How many analysts rate INmune Bio Inc. as a “Buy”Achieve breakthrough profits with expert advice - Jammu Links News
New Product Launches: Will They Boost INmune Bio Inc. Stock in 2025Best Stocks for Capital Safety - metal.it
0.40%
0.08%
자본화:
|
볼륨(24시간):